Navigation Links
Rising Interest in Molecular Biology Research Drives Demand for qPCR and dPCR Instrumentation, According to a Soon to be Released Report by Global Industry Analysts, Inc.
Date:9/19/2013

San Jose, California (PRWEB) September 19, 2013

Follow us on LinkedIn – GIA invites senior industry executives, domain experts, technologists and market strategists to participate in a comprehensive global research initiative studying the qPCR and dPCR Instrumentation markets. The study will examine key drivers and trends impacting the market such as increased adoption of advanced gene analysis instrumentation; increased investments in molecular biology research; rise in the number of new uses of qPCR such as in microRNA research, pharmacogenomics, and epigenetics research; intensifying pricing pressures as a result of recently expired and scheduled expiries of patents in the qPCR space; competitive challenges posed by mature market conditions in the qPCR market; growing demand for qPCR reagents as a result of increase in the volume of qPCR procedures; and technology developments and dissolution of barriers to adoption of dPCR.

Touted as important advances over traditional polymerase chain reaction (PCR) method used for quantification and clonal amplification of nucleic acids such as RNS, DNA and cDNA, quantitative real-time PCR (qPCR) and digital PCR (dPCR) instrumentation are witnessing robust growth worldwide. Increased R&D in areas such as, infectious diseases, vaccines, molecular diagnostics, microRNA/ncRNA/siRNA applications, and validation of biomarkers, is expected to benefit growth in the market. qPCR instrumentation market is witnessing the development of affordable solutions targeted at smaller laboratories. In a bid to differentiate product offerings in a relatively mature market, manufacturers are focusing on developing advanced systems with enhanced throughput, improved performance and other value-added features. A positive fallout of patent expiries in qPCR instrumentation is the surge in the commercialization and launch of new qPCR-based diagnostics and research tools.

Digital PCR (dPCR) instrumentation, on the other hand, represents an emerging market. Continuous technology developments are helping lower costs and increase market penetration of dPCR tools. Key benefits of dPCR responsible for driving its adoption in the medical research space include ability to conduct hundreds of PCR amplifications on a single sample; high performance, superior specificity, sensitivity, precision, and robustness; ability to perform absolute quantification at lower costs; and developments in microfluidic tools that help complement the use of dPCR. Clinical laboratories are forecast emerge as a promising end-use market for dPCR platforms in the coming years. dPCR is also expected to find special adoption in the field of cancer research supported by the technology’s unrivalled levels of precision in quantifying cancer-causing genes. Other emerging application areas for dPCR include next-generation sequencing (NGS), identification of rare mutations in genes, gene expression and miRNA analysis, single cell analysis, and pathogen detection.

The study estimates the global qPCR and dPCR Instrumentation market to be a multi-million dollar market, while more precise market-size and growth projections will be made available during the 2nd stage of report preparation, and data analysis.

The research and analyses will be released shortly in the form of a comprehensive research report. The report by design, will attempt to provide exhaustive analysis, data, trends, market share, market size, statistics, forecasts and competitive intelligence. The report is modeled to offer precise and unbiased, actionable market insights including in-depth segmentation of market sub-sectors, demand estimates and projections and analysis of trends in each of the sectors, identification of leading players, and the competitive structure, among others.

Developed for Manufacturers/Vendors, Strategic Planners, Business Development Executives, Management Consultants, Investment Bankers, Consulting Firms, Marketing & Sales Executives, C-Level Decision Makers, Market Strategists and Technology Domain Experts, the report helps identify the biggest opportunities in this space and offers accurate latent demand forecasting that empowers quantitative decision making among existing market players and new entrants.

For more details about how you can participate, please click here.

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

Read the full story at http://www.prweb.com/releases/qPCR_instrumentation/dPCR_instrumentation/prweb11130818.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Rising Incidence of Stroke Drives the Global Intracranial Stents Market, According to New Report by Global Industry Analysts, Inc.
2. Healthcare Sales Jobs Rising Despite Challenges Facing the Industry
3. Trending HealthEconomics.Com Pharma Pricing, Reimbursement, and Health Policy Stories Feature Rising Trend in Pharma Price Cuts to Secure Reimbursement
4. Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations, Says Frost & Sullivan
5. Providence Health & Services Selects Conflict of Interest Management System
6. Conflict of Interest Management Tool Links with ProPublicas "Dollars for Docs" Database
7. Conflict of Interest Management Tool Updated with Administrative Dashboards
8. University of California, San Francisco (UCSF) Selects Conflict of Interest Management System
9. Stanford scientists spark new interest in the century-old Edison battery
10. Conflict of Interest Management System Selected by Via Christi Health
11. 23andMe Presents Top Ten Most Interesting Genetic Findings of 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 9, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or ... pleased to announce that Biohaven has issued today the ... Connecticut (PRWEB) Dec 9, 2016 - Biohaven ... today that the U.S. Food and Drug Administration ("FDA") ... its drug candidate BHV-0223, an orally dissolving tablet being ...
(Date:12/8/2016)... PITTSBURGH , Dec. 8, 2016  The Board ... (PLSG), Western Pennsylvania,s only ... in leadership. In accordance with the succession plan developed ... several years, effective today, James (Jim) F. Jordan ... Executive Officer, succeeding John W. Manzetti , who ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... Lajollacooks4u, San ... a banner year for team building events, new program offerings and company expansion. ... expanded earlier this year to include groups of over 30 people. Ever since, Lajollacooks4u ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... platforms, the business of innovation is taking over sports. On Thursday, December 15th ... explore how technology is disrupting the playing field at a Smart Talk session. ...
Breaking Biology Technology:
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... 2016 According to the new market research report ... Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), ... market is expected to grow from USD 10.74 Billion in 2015 to ... 2016 and 2022. Continue Reading ... ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
Breaking Biology News(10 mins):